Page last updated: 2024-11-03

ono 1078 and Lung Diseases, Interstitial

ono 1078 has been researched along with Lung Diseases, Interstitial in 2 studies

pranlukast: SRS-A antagonist; leukotriene D4 receptor antagonist

Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chohnabayashi, N1
Sugiura, R1
Nishimura, N1
Takahashi, N1
Iwanaga, T1
Aizawa, H1
Koto, H1
Watanabe, K1
Kishikawa, R1
Ikeda, T1
Shoji, S1
Nishima, S1
Hara, N1

Reviews

1 review available for ono 1078 and Lung Diseases, Interstitial

ArticleYear
[Adverse effects of leukotriene-antagonists].
    Nihon rinsho. Japanese journal of clinical medicine, 2007, Oct-28, Volume: 65 Suppl 8

    Topics: Acetates; Anaphylaxis; Chemical and Drug Induced Liver Injury; Chromones; Cyclopropanes; Drug Intera

2007

Other Studies

1 other study available for ono 1078 and Lung Diseases, Interstitial

ArticleYear
Acute interstitial pneumonia induced by ONO-1078 (pranlukast), a leukotriene receptor antagonist.
    Internal medicine (Tokyo, Japan), 2001, Volume: 40, Issue:8

    Topics: Acute Disease; Anti-Asthmatic Agents; Asthma; Chromones; Diagnosis, Differential; Female; Humans; Le

2001